top of page
Browse by category
Search


Endoscopic sleeve gastroplasty gains momentum as a step forward in obesity care
About one in six European adults now live with obesity, putting them at greater risk for type 2 diabetes, heart disease and some...


Journal Watch 30/4/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


No significant differences in 30-day serious complications between ESG and LSG, but ESG associated with decreased ED utilisation
There are no significant differences in rates of 30-day serious complications between endoscopic sleeve gastroplasty (ESG) and...


Journal Watch 9/4/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


IFSO Bariatric Endoscopy Committee endorses endoscopic sleeve gastroplasty as an effective and valuable treatment for obesity
The IFSO Bariatric Endoscopy Committee has endorsed endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for...


Journal Watch 6/11/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Journal Watch 19/06/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Journal Watch 5/06/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Journal Watch 17/04/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Endoscopic sleeve gastroplasty more cost-effective than with semaglutide
An economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...
Browse by tag






bottom of page